Molecular mechanism of resveratrol inhibiting proliferation of human lung cancer cells through inducing cell cycle arrest and apoptosis
Xiaotian GAO,Qiuping RONG,Zeqing SONG
DOI: https://doi.org/10.13604/j.cnki.46-1064/r.2017.04.07
2017-01-01
Abstract:Objective To elucidate the potential action mechanisms of resveratrol on human lung cancer cell lines.Methods The MTT method was used to detect the cell proliferation activity of the lung cancer cell lines A549 and H1299, and the Western blot method was used to detect the expressions of the apoptosis related proteins (cleaved caspase-3, cleaved caspase-7, cleaved caspase-9, and cleaved PARP) and the cell cycle related proteins (cyclin D1, cyclin D3, CDK2, CDK4, CDK6, p53, p18, p21 and p27).The flow cytometry was used to detect the cell cycle change and apoptosis situation of resveratrol-treated cell populations.Results Resveratro] displayed the concentration-dependent inhibitory effect in lung cancer cell lines A549 and H1299 growth.Treated with resveratrol, the expression levels of cyclin D1, cyclin D3 and CDK2 proteins were up-regulated but the expression levels of CDK4, CDK6, p53, p18, p21 and p27 were down-regulated in A549 and H1299 cell lines.There was an obvious up-regulation to the expression levels of cleaved caspase-3, cleaved caspase-7, cleaved caspase-9, cleaved PARP in A549 and H1299 cell lines with resveratrol treatment.The flow cytometry detection showed that with the increase of the concentration of resveratrol, the apoptosis proportion increased in A549 and H 1299 lung cancer cell lines and the cell cycle was blocked in G1/S phase obviously.Conclusions Resveratrol can promote the caspase activation and cell apoptosis, and down-regulate the expression levels of cyclin D1, cyclin D3 and CDK2, but up-regulate the expression levels of CDK4, CDK6, p53, p18, p21 and p27, which may be the key mechanisms that resveratrol induces G1/S phase block in human lung cancer cells.